Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO)

1. Gil, M.J.
2. De Las Peñas, R.
3. Reynés, G.
4. Balañá, C.
5. Peréz-Segura, P.
6. García-Velasco, A.
7. Mesia, C.
8. Gallego, Ó.
9. Fernández-Chacón, C.
10. Martínez-García, M.
11. Herrero, A.
12. Andrés, R.
13. Benavides, M.
14. Quintanar, T.
15. Pérez-Martin, X.